AMGEN BIOFARMACEUTICA, LDA secures contract for General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents - 261G000462 - Adalimumab 40 mg/0,4 ml sol inj biossimilar caneta

Portugal, May 15 -- Portugal based AMGEN BIOFARMACEUTICA, LDA has secured contract from Unidade Local de Saude Santa Maria, E.P.E. for General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents - 261G000462 - Adalimumab 40 mg/0,4 ml sol inj biossimilar caneta. The value of the contract is worth 39664400 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....